Improving Exercise Adherence With App Technology for At-Risk Adults Living in Rural Kansas and Nebraska
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-85
SponsorCreighton University
About this trial
Alzheimer's disease and related dementias are a public health crisis impacting individuals across the world. In the United States, adults living in rural areas face an elevated risk for cognitive impairment mainly due to disparities in care, higher sedentary behavior, and reduced education. This project proposes to assess the impact of a remotely delivered exercise program (i.e., RemoteEx+) through a smartphone application. The app is programmed by our team and provides video demonstrations of exercises, workout regimes, motivational messaging, and weekly ADRD risk reduction education. The project aims to assess with a pre/post design the following aims:
* Aim 1. Assess the RemoteEx+ intervention exercise adherence, efficacy, enjoyment, and quality of life. We hypothesize that rural adults will report high exercise adherence (80% of session adherence), efficacy (\>50% on Self Efficacy for Exercise), and enjoyment (\>5.0 on Intrinsic Motivation Inventory - Interest / Enjoyment Subscale) and that these variables will be positively correlated with quality of life scores (36-Item Short Form Health Survey \[SF-36\]) * Aim 2. Determine the impact of a technology-driven exercise program on blood pressure and functional mobility associated with dementia risk. We hypothesize that the exercise program will result in improvements in blood pressure and functional mobility (2-minute step test and 30-second chair rise test) and that participants with high exercise adherence will see the greatest improvements in biomarkers associated with reduced dementia risk. * Aim 3. Reduce health disparities among rural-dwelling Nebraska and Kansas residents. We hypothesize that RemoteEx+ will reduce barriers to exercise (Barriers to Being Active Quiz and improve knowledge surrounding dementia and modifiable risk factors (Dementia Knowledge Assessment Tool - Version 2 \[DKAT2\]) that will result in fewer lifestyle-related health disparities for the communities involved in this study.
The results from this project will inform whether RemoteEx+ has an impact on the stated outcomes above for adults living in rural areas.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age 40-85 years
Characterized as underactive by the Telephone Assessment of Physical Activity (TAPA)50
Self-reported proficiency in English
Own a smartphone and willing to download an application
Disqualifiers
Contraindications to high-intensity exercise
Cognitive impairment (<19 on the Telephone Montreal Cognitive Assessment [MoCA])
Neurodegenerative or acute neurological diagnoses (e.g., Parkinson's disease, stroke, traumatic brain injury)
Orthopedic surgery or injuries in the last 6 months
Trial design
Design model
Single group
Treatments tested in this trial
RemoteEx+ Programming
BehavioralThe exercise program will include video instruction for all exercises, motivational cues, and ADRD risk education throughout the 16-week exercise program to encourage exercise adherence. RemoteEx+ is optimized to enhance exercise knowledge surrounding dementia risk factors to facilitate ADRD risk reduction and overall health improvement. The purpose of this study is to investigate the efficacy of RemoteEx+ on health outcomes associated with dementia risk in underactive rural adults.
Treatment groups
54 Participants
are divided into 1 treatment groupGroup A: RemoteEx+ ProgramExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Systolic Blood Pressure
Time frame
Baseline and Week 16Secondary outcomes
1
Cardiovascular Endurance
2-Minute Step Test
Time frame
Baseline and Week 162
Lower Extremity Strength
30-second chair rise test
Time frame
Baseline and Week 163
Exercise Adherence
% of sessions completed over the 16-week program
Time frame
Baseline and Week 164
Exercise Efficacy
Self Efficacy for Exercise (SEE) Scale (points)
Time frame
Baseline and Week 16Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov